MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Epizyme Company Profile (NASDAQ:EPZM)

Consensus Ratings for Epizyme (NASDAQ:EPZM) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $24.75 (137.52% upside)

Analysts' Ratings History for Epizyme (NASDAQ:EPZM)
Show:
DateFirmActionRatingPrice TargetActions
4/19/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Citigroup Inc.Initiated CoverageBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016HC WainwrightUpgradeNeutral -> Buy$22.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/10/2016MizuhoLower Price TargetBuy$26.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016WedbushReiterated RatingOutperform$33.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016RBC CapitalLower Price TargetOutperform$39.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/9/2016JMP SecuritiesLower Price TargetMarket Outperform$42.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/22/2015SunTrustInitiated CoverageBuy$21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 4/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha